Skip to main content
Caplight Logo









Pacegenix

Pacegenix

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://pacegenix.com

Last Round

Early Stage

VC

Mar 11, 2026

Company Overview

Pacegenix operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. It was founded in 2024.

Pacegenix is a biotechnology company that develops precision cardiology therapeutics designed to treat heart rhythm disorders and improve outcomes in patients with complex arrhythmias.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Pacegenix Comparables

Compare Pacegenix with similar companies based on industry and business-model similarity.

No comparables are published for Pacegenix. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Pacegenix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCMar 11, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Pacegenix Investors

Notable investors and investment history

Pacegenix investors
InvestorRounds
Genesis BioCapitalEarly Stage VC, Accelerator
Eshelman VenturesEarly Stage VC
aMoonEarly Stage VC
LDV PartnersEarly Stage VC

Pacegenix Filings

Explore SEC and related filing metadata, where available.

Pacegenix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Pacegenix's valuation, stock price, and market status.

Is Pacegenix a public or private company?

Pacegenix is a private company.

What is the current stock price of Pacegenix?

Pacegenix is a private company, so its shares have no public market price. Caplight tracks Pacegenix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Pacegenix worth (valuation)?

Valuation information for Pacegenix is not publicly available.

Can I buy Pacegenix stock?

Pacegenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Pacegenix's last funding round?

Pacegenix's most recent funding round was Early Stage VC on March 11, 2026.

Who are the main investors in Pacegenix?

Key investors in Pacegenix include Genesis BioCapital.

Will Pacegenix IPO soon?

No public IPO plans have been announced for Pacegenix.

How can I track Pacegenix secondary market activity?

Caplight tracks bids, offers, and trades in Pacegenix's shares on secondary markets.

Firmographic Details

HeadquartersCambridge, Massachusetts
Year Founded2024
Last FundingMar 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?